Physician profile
Melody C Tharp
NPI 1396743571
$8,894.41
in general payments reported to CMS, 2019-2025
48 companies · $1,291 in 2025
The $1,291 reported for 2025 was more than what 90% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,622 · 2020: $1,528 · 2021: $244 · 2022: $1,089 · 2023: $1,594 · 2024: $1,526 · 2025: $1,291.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,346 · Education: $64.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,345.88 |
| Education | $64.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $974.62 | 2019-2025 | |
| Novo Nordisk INC | $957.73 | 2019-2025 | Ozempic, Wegovy, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $900.20 | 2019-2025 | Airsupra, Breztri, Farxiga |
| Amgen INC. | $843.36 | 2019-2025 | Repatha, Otezla, Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $573.37 | 2019-2025 | Jardiance, Spiriva Respimat, Stiolto Respimat |
| Abbvie INC. | $563.04 | 2020-2025 | Vraylar, Qulipta, Ubrelvy |
| Lilly USA, LLC | $434.09 | 2019-2024 | Mounjaro, Zepbound, Jardiance |
| Glaxosmithkline, LLC. | $432.47 | 2019-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Merck Sharp & Dohme LLC | $377.05 | 2019-2022 | |
| Amarin Pharma, INC. | $277.02 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $182.49 | 2019-2025 | Eliquis, Camzyos |
| Allergan, INC. | $176.82 | 2019-2020 | |
| Dexcom, INC. | $176.44 | 2023-2025 | Dexcom G6 Transmitter |
| Sanofi-Aventis U.S. LLC | $159.84 | 2019-2023 | |
| Kowa Pharmaceuticals America, INC. | $159.74 | 2019-2025 | Zoryve |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $157.08 | 2022-2025 | Caplyta |
| Astellas Pharma US INC | $144.59 | 2019-2024 | Veozah, Myrbetriq |
| Idorsia Pharmaceuticals US INC | $110.95 | 2022-2024 | Quviviq |
| Takeda Pharmaceuticals U.S.A., INC. | $101.96 | 2019-2023 | Trintellix |
| Vanda Pharmaceuticals INC. | $97.22 | 2020 | |
| Phathom Pharmaceuticals, INC. | $89.35 | 2024-2025 | Voquezna |
| Arbor Pharmaceuticals, INC. | $77.16 | 2019-2022 | |
| Axsome Therapeutics, INC. | $62.01 | 2023-2025 | Auvelity |
| Abbott Laboratories | $58.16 | 2023-2025 | Freestyle Libre 3 |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $57.27 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $55.57 | 2023 | |
| Novartis Pharmaceuticals Corporation | $47.94 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $47.93 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $46.14 | 2022 | |
| Inogen, INC. | $44.64 | 2022 | |
| Currax Pharmaceuticals LLC | $43.47 | 2022-2023 | Contrave |
| Lundbeck LLC | $41.00 | 2024-2025 | Rexulti |
| Philips North America LLC | $39.24 | 2024 | (Ck7) Extended Holter |
| Eisai INC. | $37.59 | 2020 | |
| Azurity Pharmaceuticals, INC. | $36.39 | 2023-2025 | Edarbyclor, Edarbi |
| Teva Pharmaceuticals USA, INC. | $34.73 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $33.55 | 2020-2022 | |
| Exact Sciences Corporation | $31.29 | 2024-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Silk Road Medical, INC. | $28.72 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Baxter Healthcare | $25.71 | 2024 | Hillrom - Carnation Ambulatory Monitor |
| Otsuka America Pharmaceutical, INC. | $24.94 | 2022 | |
| Medtronic, INC. | $22.24 | 2025 | Minimed 780g |
| Radius Health, INC. | $21.77 | 2019 | |
| Sumitomo Pharma America, INC. | $19.75 | 2024 | Gemtesa |
| Genentech USA, INC. | $18.24 | 2019 | |
| Seqirus USA INC | $17.69 | 2025 | Flucelvax, Fluad |
| Medtronic Vascular, INC. | $17.33 | 2020 | |
| Endo Pharmaceuticals INC. | $14.51 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melody Tharp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.